TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond. Our offerings include Patient Recruitment Management - an all-in-one platform to simplify and accelerate clinical trial awareness, engagement and recruitment, and Remote Data Collection - a fully scalable eCOA/ePRO solution for global clinical trials. For more information, go to https://www.trialx.com/

InnoMedica is a ground-breaking Swiss biotech with the mission to enhance therapies for diseases with great unmet therapeutic needs through further development and new applications of our patented nanotechnology. Our nanotechnology platform is based on particularly small and uniform liposomes with an intelligent surface structure, making medical use of the body's natural logistics for the distribution of molecules. This allows the packaging of active ingredients which cannot reach the target in sufficient quantities or cause severe side effects when applied in high dosages. InnoMedica has applied our proprietary delivery platform to develop treatments for diseases and conditions in different therapeutic areas, with the objective of significantly improving the standard of care for patients with unmet needs.  For more information, visit https://innomedica.com/en/

For more information, visit https://www.asahi-kasei.com/

We are an entrepreneurial startup with innovative ideas that aim to contribute to solutions that will improve the quality of life. Our products are designed to help improve the health of the most vulnerable and in-need individuals by offering remote patient monitoring digital healthcare solutions for therapeutic management and Clinical Trials. For more information, go to: https://www.rxkeeper.com/

Topography Health is rethinking the entire research ecosystem, creating a more comprehensive platform to enhance care options for patients and delivering high quality evidence for sponsors. For more information, go to https://www.jointopo.com/.

RealTime eClinical Solutions is a leading eClinical technology provider reshaping the landscape of clinical trials with its comprehensive eClinical platform. Purpose-built for clinical research sites, site networks, AMCs, sponsors, and CROs, the platform goes beyond traditional CTMS to empower research and business workflows for modern-day clinical trials from trial award and study start-up through to trial execution. RealTime helps organizations manage the research and business of clinical trials, together, with software solutions including CTMS, eReg/eISF, eSource, participant payments (SitePay/GlobalPay), engagement solutions (Text, eConsent, and MyStudyManager™ Participant Portal), and Devana for pipeline management, business intelligence, and process and performance metrics. For more information, go to https://realtime-eclinical.com/.

RxE2 is entirely revolutionizing how clinical trials are conducted by utilizing, for the first time ever, community pharmacists, powered by our cutting-edge technology that provides patient recruitment, dispensing, counseling, and operational services to the pharmaceutical and biotech industries. For more information, go to https://www.rxe2.com/.

OxSonics is a pioneering clinical-stage company on a mission to transform cancer treatment with its breakthrough SonoTran® technology, utilising Innovative proprietary sonosensitive particles, co-administered with anti-cancer drugs, and “activated” by a novel ultrasound device. This enhances the delivery of oncology drugs into solid tumours, improving efficacy and/or reducing off-target toxicity. To learn more please visit: https://oxsonics.com/

MYRA EB SYSTEMS revolutionizes clinical trials with VR solutions that enhance patient recruitment, retention, and engagement. Our VR technology supports remote monitoring, immersive training for clinical staff, and streamlined data collection and analysis, leading to more efficient, accurate trials and improved patient outcomes in drug development. For more information, go to https://myraebsystems.com/

Biora Therapeutics is a clinical-stage biotech developing two smart pill-based therapeutics platforms: the NaviCap™ platform for colon-targeted treatment of IBD, designed to improve patient outcomes through treatment at the site of disease in the gastrointestinal tract, and the BioJet™ platform for oral delivery of large molecules, designed to replace injection with needle-free, oral delivery for better management of chronic diseases. For more information, please visit https://www.bioratherapeutics.com/

Asahi Kasei Corporation (Headquarters: Tokyo, Japan) is the leading manufacturer and supplier of functional pharma excipients, such as microcrystalline cellulose, in Japan. In order to further address the rising demands in formulation research, we are now developing a cutting-edge pharma excipient primarily for injections: hyaluronic acid nanogel, Sonanos™. The Sonanos™ can act as a DDS carrier, facilitating sustained release or solubility enhancement of APIs. For more information, please visit https://www.ceolus.com/en/sonanos/hyaluronic_acid_nanogel/

In an era of accelerating change, Exponent is the only premium engineering and scientific consulting firm with the depth and breadth of expertise to solve our clients’ most profoundly unique, unprecedented, and urgent challenges. Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world. For more information, go to: https://www.exponent.com/